![Drug maker Teva to fire 350 workers in efficiency bid for southern Israeli plant | The Times of Israel Drug maker Teva to fire 350 workers in efficiency bid for southern Israeli plant | The Times of Israel](https://static.timesofisrael.com/www/uploads/2019/02/IMG_7041-1-e1550576947501.jpg)
Drug maker Teva to fire 350 workers in efficiency bid for southern Israeli plant | The Times of Israel
![Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to](https://pbs.twimg.com/media/FCuXMz3X0AU81CB.jpg)
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
![Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US](https://c8.alamy.com/comp/2CWY46Y/bristol-myers-squibb-ceo-giovanni-caforio-teva-pharmaceuticals-ceo-kare-schultz-and-celgene-corporation-former-ceo-mark-alles-are-sworn-in-prior-to-testifying-by-video-conference-during-a-hearing-before-the-us-house-of-representatives-committee-on-oversight-and-reform-focused-on-the-cost-of-prescription-drugs-in-the-us-capitol-in-washington-us-september-30-2020-greg-nashpool-via-reuters-2CWY46Y.jpg)